FR2450833A1 - Derives de benzazepine - Google Patents

Derives de benzazepine

Info

Publication number
FR2450833A1
FR2450833A1 FR8002469A FR8002469A FR2450833A1 FR 2450833 A1 FR2450833 A1 FR 2450833A1 FR 8002469 A FR8002469 A FR 8002469A FR 8002469 A FR8002469 A FR 8002469A FR 2450833 A1 FR2450833 A1 FR 2450833A1
Authority
FR
France
Prior art keywords
group
hydrogen
lower alkyl
hydroxy
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8002469A
Other languages
English (en)
French (fr)
Other versions
FR2450833B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2450833A1 publication Critical patent/FR2450833A1/fr
Application granted granted Critical
Publication of FR2450833B1 publication Critical patent/FR2450833B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/34—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
FR8002469A 1979-02-07 1980-02-05 Derives de benzazepine Granted FR2450833A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1011879A 1979-02-07 1979-02-07
US1670979A 1979-03-01 1979-03-01
CH51080 1980-01-22

Publications (2)

Publication Number Publication Date
FR2450833A1 true FR2450833A1 (fr) 1980-10-03
FR2450833B1 FR2450833B1 (enExample) 1983-06-10

Family

ID=27172162

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8002469A Granted FR2450833A1 (fr) 1979-02-07 1980-02-05 Derives de benzazepine

Country Status (26)

Country Link
EP (1) EP0014470B1 (enExample)
AT (1) ATE14225T1 (enExample)
AU (1) AU535233B2 (enExample)
CA (1) CA1138863A (enExample)
DD (1) DD149066A5 (enExample)
DE (2) DE3004381A1 (enExample)
ES (1) ES488311A0 (enExample)
FI (1) FI68832C (enExample)
FR (1) FR2450833A1 (enExample)
GB (1) GB2043636B (enExample)
HU (1) HU182662B (enExample)
IE (1) IE49630B1 (enExample)
IL (1) IL59316A (enExample)
IN (1) IN151574B (enExample)
IT (1) IT1140535B (enExample)
LU (1) LU82143A1 (enExample)
MC (1) MC1314A1 (enExample)
MT (1) MTP864B (enExample)
NL (1) NL8000715A (enExample)
NO (1) NO153138C (enExample)
NZ (1) NZ192803A (enExample)
PT (1) PT70794B (enExample)
RO (1) RO79168A (enExample)
SE (1) SE8000964L (enExample)
SU (1) SU1181547A3 (enExample)
YU (1) YU32380A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK347781A (da) * 1980-08-05 1982-02-06 Hoffmann La Roche Fremgangsmaade til fremstilling af pyrimido-(4,5-d) (2)-benzezepiner eller farmaceutisk acceptable salte deraf
EP0273697A3 (en) * 1986-12-30 1989-11-29 Merck & Co. Inc. 2-benzazepines with 5- and 6- membered heterocyclic rings
US5013333A (en) * 1990-04-13 1991-05-07 Tennant Company Unattended air cleaning system for surface maintenance machine
EP1751136B1 (en) 2004-05-07 2014-07-02 Amgen Inc. Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
KR101792651B1 (ko) 2004-05-14 2017-11-20 밀레니엄 파머슈티컬스 인코퍼레이티드 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 화합물을 포함하는 약학적 조성물
WO2008021038A2 (en) 2006-08-09 2008-02-21 Millennium Pharmaceuticals, Inc. Pyridobenzazepine compounds and methods for inhibiting mitotic progression
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CN102264368B (zh) 2008-12-22 2014-09-10 米伦纽姆医药公司 极光激酶抑制剂与抗cd20抗体的组合
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
WO2011103089A1 (en) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
EP2976086B1 (en) 2013-03-22 2020-10-14 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
EP3324976A4 (en) 2015-07-21 2019-03-27 Millennium Pharmaceuticals, Inc. ADMINISTRATION OF KINASE AURORA INHIBITOR AND CHEMOTHERAPEUTIC AGENTS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2272662A1 (enExample) * 1974-06-03 1975-12-26 Ciba Geigy Ag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2272662A1 (enExample) * 1974-06-03 1975-12-26 Ciba Geigy Ag

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/78 *

Also Published As

Publication number Publication date
AU5529680A (en) 1980-08-14
ATE14225T1 (de) 1985-07-15
NO800316L (no) 1980-08-08
NZ192803A (en) 1984-08-24
NO153138B (no) 1985-10-14
SE8000964L (sv) 1980-08-08
PT70794B (en) 1981-06-11
SU1181547A3 (ru) 1985-09-23
YU32380A (en) 1983-12-31
PT70794A (en) 1980-03-01
EP0014470A2 (de) 1980-08-20
IN151574B (enExample) 1983-05-28
EP0014470B1 (de) 1985-07-10
MC1314A1 (fr) 1981-03-10
ES8101590A1 (es) 1980-12-16
DD149066A5 (de) 1981-06-24
IE800227L (en) 1980-08-07
IE49630B1 (en) 1985-11-13
FI68832C (fi) 1985-11-11
DE3004381A1 (de) 1980-09-04
IL59316A (en) 1983-07-31
HU182662B (en) 1984-02-28
FI800367A7 (fi) 1980-08-08
IT8019740A0 (it) 1980-02-06
RO79168A (ro) 1982-06-25
GB2043636A (en) 1980-10-08
NL8000715A (nl) 1980-08-11
AU535233B2 (en) 1984-03-08
FI68832B (fi) 1985-07-31
IT1140535B (it) 1986-10-01
CA1138863A (en) 1983-01-04
IL59316A0 (en) 1980-05-30
DE3070847D1 (en) 1985-08-14
NO153138C (no) 1986-01-22
GB2043636B (en) 1983-05-11
LU82143A1 (de) 1981-09-10
MTP864B (en) 1981-04-29
EP0014470A3 (en) 1982-02-10
FR2450833B1 (enExample) 1983-06-10
ES488311A0 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
DD283999A5 (de) Verfahren zur herstellung von prolinderivaten und verwandten verbindungen
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
NO159795C (no) Fremgangsmaate for fremstilling av 2-penemforbindelser.
KR900006318A (ko) 피페리디닐 벤즈이미다졸
FI810389L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
GB1324469A (en) Derivatives of benzodiazepines
DE69311837D1 (de) Steroide zur Behandlung von Prostatisch-Hypertrophe, ihre Herstellung und Verwendung
BE1002102A4 (fr) Derives de l'acide quinoleinecarboxylique.
KR860007221A (ko) 시클로펜타[d] 피리미딘 유도체의 제조방법
MA69177A1 (fr) Agents de dégradation bifonctionnels de quinolone-bcl6 tricycliques
KR900003155A (ko) 항전신병특성을 가진 3-피페라지닐벤즈아졸 유도체
BE901239A (fr) Nouveaux derives d'aminoguanidine et procede pour leur preparation.
FR2471381A1 (fr) Derives de l'ergoline, procede pour les preparer et leur emploi comme medicaments
ATE50773T1 (de) Alkylresorcinolphosphite.
ATE37872T1 (de) Phenylinden-derivate, ihre salze, und verfahren zu ihrer herstellung.
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
KR880006239A (ko) 기라제 억제제, 그의 제조방법 및 용도
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
EP0002978A2 (fr) Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique
ATE3149T1 (de) Isatinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB1397731A (en) Monothiachromone-2-carboxylic acids
SE8501988L (sv) Iminotiazolidinderivat
GB1504694A (en) Benzo-bicyclononene derivatives
GB1191237A (en) 0,3-Diazacyclo alkeno[2,1-a]isoindole Derivatives and a process for the mnufacture thereof
KR920701199A (ko) [5(6)-(벤즈이소옥사-, 벤즈이소티아- 또는 인다졸-3-일)-1h 벤즈이미다졸-2-일]카르바메이트

Legal Events

Date Code Title Description
ST Notification of lapse